Company: KCHVR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076631
Chunk: 4

Company: Kochav Defense Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
 of the Over-Allotment Option; consequently, such 1,100,000 Founder Shares are no longer subject to forfeiture.  (2) On April 3, 2025, the Company issued an additional 4,598,333 Founder Shares to the Sponsor in a share capitalization, resulting in the Sponsor holding an aggregate of 8,433,333 Founder Shares. 

The accompanying notes are an integral part of
the unaudited condensed financial statements.

3

KOCHAV DEFENSE ACQUISITION CORP.

CONDENSED STATEMENT OF CASH FLOWS

FOR THE PERIOD FROM JANUARY 7, 2025 (INCEPTION)
THROUGH JUNE 30, 2025

(UNAUDITED)

    Cash Flows from Operating Activities: 

    Net income 
    $776,441 
  
    Adjustments to reconcile net income to net cash used in operating activities: 

    Operating costs paid through IPO Promissory Note– related party 
     53,945 
  
    Dividends earned on investments held in Trust Account 
     (919,363)
  
    Changes in operating assets and liabilities: 

    Prepaid expenses 
     (183,998)
  
    Net cash used in operating activities 
     (272,975)

    Cash Flows from Investing Activities: 

    Investment of cash into Trust Account 
     (253,000,000)
  
    Net cash used in investing activities 
     (253,000,000)

    Cash Flows from Financing Activities: 

    Proceeds from sale of Public Units, net of underwriting discounts paid 
     249,584,500 
  
    Proceeds from sale of Private Placement Units 
     5,240,500 
  
    Proceeds from IPO Promissory Note 
     117,300 
  
    Repayment of IPO Promissory Note 
     (374,794)
  
    Payment of offering costs 
     (367,517)
  
    Net cash provided by financing activities 
     254,199,989 

    Net Change in Cash 
     927,014 
  
    Cash – Beginning of period 
     — 
  
    Cash – End of period 
    $927,014 

    Noncash investing and financing activities: 

    Deferred offering costs included in accrued offering costs 
    $85,000 
  
    Deferred offering costs paid through IPO